Las Vegas, NV -- (SBWIRE) -- 12/23/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: Cereplast Inc (OTCMKTS:CERP), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Facebook Inc (NASDAQ:FB), Exeter Resource Corp. (NYSEMKT:XRA)
Cereplast Inc (OTCMKTS:CERP) managed to keep its gain at 27.50% on above-normal volume of 18.60M shares. The stock settled at $0.0051 after floating in a range of $0.0004 to $0.0051. Its latest price has reached market capitalization of $25 million. Its 52-week range has been $0.004 to $0.068. Cereplast, Inc. (Cereplast) is engaged in developing and commercializing bio-based resins through two product families: Cereplast Compostables Resins, which are compostable, renewable, ecologically sound substitutes for petroleum-based plastics, and Cereplast Sustainables resins (including the Cereplast Hybrid Resins product line), which replaces up to 90% of the petroleum-based content of traditional plastics with materials from renewable resources.
For How Long CERP will fight for Profitability? Read This Trend Analysis report
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) traded up on a volume of 150.12 million, higher than its standard daily volume. Shares have gained 16.49% to $6.43. Over the last twelve months, the stock has lost-68.59% and faced a worst price of $2.15. ARIAD Pharmaceuticals, Inc. (ARIAD) is a global oncology company focused on the discovery, development and commercialization of medicines for the cancer patients. ARIAD’s first medicine, Iclusig, is approved in the United States for the treatment of adult patients with chronic, accelerated or blast phase chronic myeloid leukemia that is resistant or intolerant to prior tyrosine kinase inhibitor (TKI) therapy or Philadelphia chromosome-positive acute lymphoblastic leukemia that is resistant or intolerant to prior TKI therapy. As of January 11, 2013, additional clinical trials of Iclusig in other cancers were ongoing.
For How Long ARIA’s Gloss will Attract Investors? Find out via this report
Facebook Inc (NASDAQ:FB) settled 0.13% higher at $55.12 on above-normal volume of 239.82M shares during the last trading day. The stock has its 12-month high at $55.89 and 52-week low price was $22.67. It traded in a range of $54.23 to $55.15 during the last trading day. Facebook, Inc. (Facebook) is engaged in building products to create utility for users, developers, and advertisers. People use Facebook to stay connected with their friends and family, to discover what is going on in the world around them, and to share and express what matters to them to the people they care about.
Why Should Investors Buy FB After the Recent Fall? Just Go Here and Find Out
In the last trading session, Exeter Resource Corp. (NYSEMKT:XRA) was up on high volume, trading at a volume of 12.63M shares versus its average daily volume of 691,728.00 shares. At $0.527, the stock has attained market capitalization of $46.63 million. Exeter Resource Corporation (Exeter) is a mineral resource exploration and development company. The Company is engaged in the business of acquisition, exploration and development of mineral properties located in the Maricunga Region, Chile.
Will XRA Continue To Move Higher? Find Out Here
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)